J. Thistlethwaite

发表

Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.

J. Bluestone, E. Woodle, D. Xu, 1999, Transplantation.

Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.

G. Szot, J. Bluestone, J. Thistlethwaite, 1999, Journal of immunology.

Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival.

G. Szot, J. Bluestone, A. Sharpe, 2000, Transplantation.

A K‐nearest neighbors survival probability prediction method

C. McCulloch, S. Zenios, J. Thistlethwaite, 2013, Statistics in medicine.

Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

P. Linsley, A. Montag, J. Bluestone, 1992, Science.

THE CORRELATION BETWEEN DONOR CHARACTERISTICS AND THE SUCCESS OF HUMAN ISLET ISOLATION1,2

J. Thistlethwaite, T. Karrison, T. Karrison, 1994, Transplantation.

Decision making in liver transplantation—Limited application of the liver donor risk index

J. Thistlethwaite, A. Aronsohn, Leslie A Mataya, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Complications and monitoring of OKT3 therapy.

A. Gaber, J. Thistlethwaite, F. Stuart, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Activation of human T cells in vivo following treatment of transplant recipients with OKT3.

J. Bluestone, E. Woodle, J. Thistlethwaite, 1990, Transplantation.

Angiographic selection criteria for living related liver transplant donors.

J. Rosenblum, J. Leef, J. Thistlethwaite, 1996, AJR. American journal of roentgenology.

Experience With Radical Resection in The Management of Proximal Bile Duct Cancer

J. Emond, J. Thistlethwaite, C. Broelsch, 1989, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.

Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis).

G. Szot, G. Gray, J. Thistlethwaite, 1999, Transplantation.

Ethics of liver transplantation with living donors.

P. Singer, J. Emond, J. Thistlethwaite, 1989, The New England journal of medicine.

Analysis of fracture prevalence in kidney-pancreas allograft recipients.

E. Woodle, J. Thistlethwaite, D. Bruce, 1998, Journal of the American Society of Nephrology : JASN.

Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.

T. Schiano, E. Woodle, J. Thistlethwaite, 1998, Transplantation.

Successful hepatic transplantation in congenital absence of recipient portal vein.

J. Emond, E. Woodle, J. Thistlethwaite, 1990, Surgery.

Risk, prognosis, and unintended consequences in kidney allocation.

L. Ross, J. Thistlethwaite, B. Hippen, 2011, The New England journal of medicine.

Bacterial infection as a complication of liver transplantation: epidemiology and risk factors.

J. Emond, J. Thistlethwaite, C. Broelsch, 1991, Reviews of infectious diseases.

Shared decision making in deceased-donor transplantation

Stefanos Zenios, Lainie Friedman Ross, S. Zenios, 2006, The Lancet.

Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation

L. Ross, J. Thistlethwaite, J. Thistlethwaite, 2016, Progress in transplantation.

Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients.

J. Thistlethwaite, A. Dasgupta, F. Stuart, 1991, American journal of nephrology.

HEPATIC ARTERY THROMBOSIS IN INFANTS A COMPARISON OF WHOLE LIVERS, REDUCED‐SIZE GRAFTS, AND GRAFTS FROM LIVING‐RELATED DONORS 1

J. Emond, J. Thistlethwaite, C. Broelsch, 1992, Transplantation.

Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade.

W. Chon, J. Thistlethwaite, S. Udani, 2010, Clinical journal of the American Society of Nephrology : CJASN.

EVOLVING USE OF OKT3 MONOCLONAL ANTIBODY FOR TREATMENT OF RENAL ALLOGRAFT REJECTION

R. Rubin, F. Delmonico, J. Thistlethwaite, 1984, Transplantation.

Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients.

J. Thistlethwaite, F. Stuart, T. Heffron, 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor.

J. Thistlethwaite, T. McKeithan, J. Hart, 1996, Transplantation.

Platelets and capillary injury in acute humoral rejection of renal allografts.

J. Thistlethwaite, M. Haas, S. Meehan, 2003, Human pathology.

Portal vein thrombosis and stenosis in pediatric liver transplantation.

E. Woodle, J. Thistlethwaite, D. Bruce, 1996, Transplantation.

The ethical assessment of innovative therapies: Liver transplantation using living donors

P. Singer, J. Emond, J. Thistlethwaite, 1990, Theoretical medicine.

Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.

E. Woodle, J. Thistlethwaite, M. Haas, 1996, Transplantation.

Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.

H. Koeppen, E. Woodle, J. Thistlethwaite, 1996, Transplantation.

Insulin Secretory Profiles and C-Peptide Clearance Kinetics at 6 Months and 2 Years After Kidney-Pancreas Transplantation

J. Sturis, K. Polonsky, E. Cauter, 1992, Diabetes.

Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.

J. Bluestone, D. Jeyarajah, J. Thistlethwaite, 1994, Journal of immunology.

A NON‐ACTIVATING “HUMANIZED” ANTI‐CD3 MONOCLONAL ANTIBODY RETAINS IMMUNOSUPPRESSIVE PROPERTIES IN VIVO

J. Bluestone, D. Jeyarajah, R. Zivin, 1994, Transplantation.

Choledochocholedochostomy without a T tube or internal stent in transplantation of the liver.

J. Emond, J. Thistlethwaite, C. Broelsch, 1990, Surgery, gynecology & obstetrics.

LIVER TRANSPLANTATION WITH REDUCED‐SIZE DONOR ORGANS

J. Emond, J. Thistlethwaite, C. Broelsch, 1988, Transplantation.

Reuse of a previously transplanted kidney: does success come with a price?

W. Chon, J. Thistlethwaite, S. Meehan, 2012, Clinical Kidney Journal.

TREATMENT WITH EITHER ANTI-CD4 OR ANTI-CD8 MONOCLONAL ANTIBODIES BLOCKS αβ T CELL-MEDIATED REJECTION OF INTESTINAL ALLOGRAFTS IN MICE

J. Thistlethwaite, J. Hart, K. Newell, 1997 .

Patterns of infection after pediatric liver transplantation.

J. Emond, J. Thistlethwaite, C. Broelsch, 1992, American journal of diseases of children.

Outcomes of Pancreatic Islet Allotransplantation Using the Edmonton Protocol at the University of Chicago

L. Philipson, W. Chon, J. Thistlethwaite, 2016, Transplantation direct.

The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.

G. Szot, J. Thistlethwaite, J. Hart, 1999, Transplantation.

Role of STAT6 signaling in the induction and long-term maintenance of tolerance mediated by CTLA4-Ig.

G. Szot, J. Bluestone, J. Thistlethwaite, 2001, Transplantation proceedings.

Transplantation and the CD28/CTLA4/B7 pathway.

J. Bluestone, J. Thistlethwaite, F. Fallarino, 2001, Transplantation proceedings.

Late complications in kidney-pancreas transplant recipients.

E. Woodle, J. Thistlethwaite, D. Bruce, 1995, Transplantation Proceedings.

Prisoners as Living Donors: A Vulnerabilities Analysis

L. Ross, J. Thistlethwaite, 2017, Cambridge Quarterly of Healthcare Ethics.

Different Mechanisms of Cardiac Allograft Rejection in Wildtype and CD28‐deficient Mice

G. Szot, J. Bluestone, J. Thistlethwaite, 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Ethics of a paired-kidney-exchange program.

L. Ross, E. Woodle, J. Thistlethwaite, 1997, The New England journal of medicine.

Children as Living Donors

L. Ross, J. Thistlethwaite, 2016 .

All living donors should not be treated equally

L. Ross, J. Thistlethwaite, W. Glannon, 2003 .

Comparison of pancreas transplantation with portal venous and enteric exocrine drainage to the standard technique utilizing bladder drainage of exocrine secretions.

E. Woodle, J. Thistlethwaite, D. Bruce, 1996, Transplantation.

The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.

A. Gaber, J. Thistlethwaite, F. Stuart, 1987, Transplantation proceedings.

REEXPOSURE TO OKT3 IN RENAL ALLOGRAFT RECIPIENTS

J. Thistlethwaite, F. Stuart, J. Stuart, 1988, Transplantation.

Effect of massive transfusion during liver transplantation on rejection and infection.

J. Emond, J. Thistlethwaite, C. Broelsch, 1988, Transplantation proceedings.

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.

R. Wiesner, F. Delmonico, G. Danovitch, 1996, Transplantation.

Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.

E. Woodle, J. Thistlethwaite, D. Bruce, 1996, Transplantation.

The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.

J. Thistlethwaite, M. Haas, P. Domer, 2001, Human pathology.

Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.

E. Woodle, J. Thistlethwaite, D. Bruce, 1998, Transplantation proceedings.

Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation.

G. Szot, J. Bluestone, G. Gray, 1997, Journal of immunology.

Cutting Edge: Membrane Lymphotoxin Regulates CD8+ T Cell-Mediated Intestinal Allograft Rejection1

J. Thistlethwaite, yang-xin fu, Zhong Guo, 2001, The Journal of Immunology.

CD8 T CELL-MEDIATED REJECTION OF INTESTINAL ALLOGRAFTS IS RESISTANT TO INHIBITION OF THE CD40/CD154 COSTIMULATORY PATHWAY

J. Thistlethwaite, J. Hart, Zhong Guo, 2001, Transplantation.

Allograft Rejection T Cell-Mediated Intestinal + Regulates CD8 Cutting Edge: Membrane Lymphotoxin

J. Thistlethwaite, J. Hart, Zhong Guo, 2001 .

From Lyon to Louisville: the need for tolerance

L. Ross, J. Thistlethwaite, 2000 .

Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation.

J. Thistlethwaite, F. Stuart, J. Stuart, 1985, Human immunology.

A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.

J. Bluestone, D. Jeyarajah, R. Zivin, 1994 .

Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.

J. Bluestone, W. Olson, A. Collins, 1992, Journal of immunology.

Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.

J. Alexander, F. Delmonico, A. Matas, 1999, Transplantation.

Ethics of liver transplantation with living donors

P. Singer, J. Emond, J. Thistlethwaite, 1990 .

Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients.

E. Woodle, J. Thistlethwaite, D. Bruce, 2000, Annals of surgery.

Allograft rejection in pediatric recipients of living related liver transplants

J. Thistlethwaite, E. Alonso, J. Piper, 1996, Hepatology.

Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.

G. Freeman, J. Bluestone, D. Lenschow, 1995, Transplantation.

Humanized, Nonmitogenic OKT3 Antibody, huOKT3γ(Ala-Ala): Initial Clinical Experience

J. Bluestone, E. Woodle, R. Zivin, 1998 .

Implications of Immunohistochemical Detection of C4d along Peritubular Capillaries in Late Acute Renal Allograft Rejection

D. Huo, J. Thistlethwaite, S. Meehan, 2005, Transplantation.

Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection.

A. Gaber, J. Thistlethwaite, F. Stuart, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

MONITORING AND COMPLICATIONS OF MONOCLONAL THERAPY Complications and Monitoring of OKT3 Therapy

J. Thistlethwaite, F. Stuart, J. Stuart, 1988 .

Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases.

E. Woodle, J. Thistlethwaite, D. Bruce, 1998, Transplantation proceedings.

The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies.

E. Woodle, J. Thistlethwaite, M. Haas, 1999, Journal of the American Society of Nephrology : JASN.

Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.

E. Woodle, J. Thistlethwaite, M. Haas, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.

E. Woodle, J. Thistlethwaite, D. Bruce, 1998, Transplantation proceedings.

Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice.

J. Thistlethwaite, J. Hart, K. Newell, 1997, Transplantation.

Pancreas-Graft Immunogenicity and Pretreatment With Anti-Class II Monoclonal Antibodies

A. Letai, J. Thistlethwaite, D. Lloyd, 1989, Diabetes.

Outcomes after kidney donation.

L. Ross, J. Thistlethwaite, 2014, JAMA.

A RANDOMIZED CLINICAL TRIAL OF INDUCTION THERAPY WITH OKT3 IN KIDNEY TRANSPLANTATION

Shu-chen Wu, T. Haverty, J. Thistlethwaite, 1993, Transplantation.

Right Heart Dysfunction, Pulmonary Embolism, and Paradoxical Embolization during Liver Transplantation: A Transesophageal Two‐Dimensional Echocardiographic Study

S. Feinstein, J. Emond, M. Roizen, 1989, Anesthesia and analgesia.

Pediatric orthotopic liver transplantation: multifactorial predictions of blood loss.

J. Emond, J. Thistlethwaite, C. Broelsch, 1986, Anesthesiology.

The 1966 Ciba Symposium on Transplantation Ethics: 50 Years Later.

L. Ross, J. Thistlethwaite, 2016, Transplantation.

Living Donation by Individuals with Life-Limiting Conditions

L. Ross, J. Thistlethwaite, 2019, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

Disclosing Health and Health Behavior Information between Living Donors and Their Recipients.

L. Ross, J. Thistlethwaite, D. Mandelbrot, 2015, Clinical journal of the American Society of Nephrology : CJASN.

The nondirected live-kidney donor: ethical considerations and practice guidelines: A National Conference Report1

L. Siminoff, F. Delmonico, G. Danovitch, 2002, Transplantation.

Should all living donors be treated equally?

J. Thistlethwaite, W. Glannon, L. Friedman Ross, 2002, Transplantation.

Different Standards Are Not Double Standards: All Elective Surgical Patients Are Not Alike

L. Ross, J. Thistlethwaite, W. Glannon, 2012, The Journal of Clinical Ethics.

Age and equity in liver transplantation: An organ allocation model

L. Ross, J. Thistlethwaite, A. Cucchetti, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Attitudes of Minority Patients with End‐Stage Renal Disease Regarding ABO‐Incompatible List‐Paired Exchanges

L. Ross, J. Thistlethwaite, L. F. Ross, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Developing an ethics framework for living donor transplantation

L. Ross, J. Thistlethwaite, 2018, Journal of Medical Ethics.

Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.

E. Woodle, J. Thistlethwaite, D. Bruce, 1997, Transplantation proceedings.

Indications for liver transplantation in pediatric patients.

J. Emond, J. Thistlethwaite, C. Broelsch, 1991, Clinical transplantation.

Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients

D. Snydman, R. Rubin, J. Thistlethwaite, 1995, Annals of Internal Medicine.

The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: case report and literature review.

J. Thistlethwaite, B. Spargo, M. Josephson, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Liver transplantation in the first three months of life.

E. Woodle, J. Thistlethwaite, R. Busuttil, 1998, Transplantation.

Transplantation of Two Patients with One Liver: Analysis of a Preliminary Experience with 'Split‐liver' Grafting

J. Emond, J. Thistlethwaite, C. Broelsch, 1990, Annals of surgery.

Reduced‐size orthotopic liver transplantation: Use in the management of children with chronic liver disease

J. Emond, J. Thistlethwaite, C. Broelsch, 1989, Hepatology.

Combined liver and kidney transplantation in children.

E. Woodle, J. Thistlethwaite, D. Bruce, 1998, Transplantation.

Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.

J. Thistlethwaite, K. Newell, C. Rubin, 1997, The Journal of pediatrics.

Liver transplantation in children from living related donors. Surgical techniques and results.

J. Emond, J. Thistlethwaite, C. Broelsch, 1991, Annals of surgery.

Application of Reduced‐size Liver Transplants as Split Grafts, Auxiliary Orthotopic Grafts, and Living Related Segmental Transplants

J. Emond, J. Thistlethwaite, C. Broelsch, 1990, Annals of surgery.

Clinical course and management of inflammatory bowel disease after liver transplantation.

H. Conjeevaram, T. Schiano, J. Thistlethwaite, 1998, Transplantation.

Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts.

A. Gaber, J. Thistlethwaite, F. Stuart, 1987, The American surgeon.

Kidney Donor Profile Index Does Not Accurately Predict the Graft Survival of Pediatric Deceased Donor Kidneys

L. Ross, J. Thistlethwaite, W. Parker, 2016, Transplantation.

IMMUNOLOGIC CHARACTERIZATION OF MHC RECOMBINANT SWINE: PRODUCTION OF SLA CLASS SPECIFIC ANTISERA AND DETECTION OF IA ANTIGENS ON BOTH B AND NON‐B PBL

J. Lunney, D. Sachs, J. Thistlethwaite, 1983, Transplantation.

Effect of class II antigen matching on renal allograft survival in miniature swine

M. Pescovitz, H. Auchincloss, D. Sachs, 1984, The Journal of experimental medicine.

Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group.

R. Wiesner, J. Roberts, R. Freeman, 1997, Transplantation.

Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease.

J. Thistlethwaite, C. Broelsch, A. Baker, 1988, The Journal of infectious diseases.

Ethical Analysis and Policy Recommendations Regarding Domino Liver Transplantation

L. Ross, G. Mazariegos, J. Thistlethwaite, 2018, Transplantation.

Omega jejunoduodenal anastomosis for pancreas transplant.

J. Thistlethwaite, J. Millis, James W. Williams, 2006, Journal of the American College of Surgeons.

Liver Transplantation, Including the Concept of Reduced‐size Liver Transplants in Children

J. Emond, J. Thistlethwaite, C. Broelsch, 1988, Annals of surgery.

An analysis of hepatic retransplantation in children.

E. Woodle, J. Thistlethwaite, D. Bruce, 1998, Transplantation.

BILIARY COMPLICATIONS IN PEDIATRIC LIVER TRANSPLANTATION A COMPARISON OF REDUCED‐SIZE AND WHOLE GRAFTS 1

J. Emond, J. Thistlethwaite, C. Broelsch, 1992, Transplantation.

Pathogenesis of early operative site infections after orthotopic liver transplantation.

J. Thistlethwaite, K. Newell, P. Arnow, 1998, Transplantation.

Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients.

E. Woodle, J. Thistlethwaite, M. Haas, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

REDUCED ACUTE REJECTION AND SUPERIOR 1-YEAR RENAL ALLOGRAFT SURVIVAL WITH BASILIXIMAB IN PATIENTS WITH DIABETES MELLITUS1

J. Thistlethwaite, M. Hall, B. Nashan, 2000 .

Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group.

J. Thistlethwaite, B. Nashan, M. Hall, 1998, Transplantation.

PROLONGED SURVIVAL OF CLASS II MATCHED RENAL ALLOGRAFTS expression of class II

H. Auchincloss, D. Sachs, J. Thistlethwaite, 2003 .

Transplantation in miniature swine. X. Evidence for non-SLA-linked immune response gene(s) controlling rejection of SLA-matched kidney allografts.

M. W. Flye, D. Sachs, J. Thistlethwaite, 1981, Transplantation.

T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation.

A. Gaber, J. Thistlethwaite, F. Stuart, 1987, Transplantation proceedings.

Correlation of the outcome of renal transplantation with T cell flow cytometric immunofluorescence crossmatch results

A. Gaber, J. Thistlethwaite, M. Buckingham, 1986 .

Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.

A. Gaber, J. Thistlethwaite, F. Stuart, 1987, Transplantation proceedings.

General aspects of cytokine-release syndrome: timing and incidence of symptoms.

D. Jeyarajah, J. Thistlethwaite, 1993, Transplantation proceedings.

Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.

V. Engelhard, J. Bluestone, D. Jeyarajah, 1994, Journal of immunology.

OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.

J. Bluestone, E. Woodle, J. Thistlethwaite, 1991, Transplantation.

Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1

J. Emond, J. Thistlethwaite, P. Whitington, 1993, The Lancet.

OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies.

A. Monaco, D. Abramowicz, P. Kinnaert, 1995, Transplantation proceedings.

Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies.

J. Bluestone, E. Woodle, J. Thistlethwaite, 1991, Transplantation.

Role of STAT4 and STAT6 Signaling in Allograft Rejection and CTLA4-Ig-Mediated Tolerance1

J. Bluestone, J. Thistlethwaite, Zhong Guo, 2000, The Journal of Immunology.

Tolerance Allograft Rejection and CTLA 4-Ig-Mediated Role of STAT 4 and STAT 6 Signaling in

G. Szot, J. Bluestone, J. Thistlethwaite, 2000 .

Does depletion of donor dendritic cells in an organ allograft lead to prolongation of graft survival on transplantation?

M. Weiser, J. Thistlethwaite, F. Stuart, 1989, Transplantation proceedings.

Use of polytetrafluoroethylene patch for temporary wound closure after pediatric liver transplantation.

E. Woodle, J. Thistlethwaite, D. Bruce, 1996, Transplantation.

Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression.

E. Woodle, J. Thistlethwaite, D. Bruce, 1998, Transplantation proceedings.

Minors as Living Solid-Organ Donors

L. Ross, J. Thistlethwaite, 2008, Pediatrics.

Percapsular and percutaneous embolization of renal transplant pseudoaneurysm and AV fistula: Case report

C. Sennett, J. Thistlethwaite, R. Messersmith, 1989, CardioVascular and Interventional Radiology.

Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.

E. Woodle, J. Thistlethwaite, F. Stuart, 1989, Transplantation Proceedings.

Imaging of pancreatic transplantation using portal venous and enteric exocrine drainage.

A. Dachman, J. Thistlethwaite, D. Bruce, 1998, AJR. American journal of roentgenology.

Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year.

E. Woodle, J. Thistlethwaite, D. Bruce, 1996, Transplantation.

Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.

E. Woodle, J. Thistlethwaite, D. Bruce, 1998, Transplantation proceedings.

Gender and race/ethnicity differences in living kidney donor demographics: Preference or disparity?

L. Ross, J. Thistlethwaite, 2021, Transplantation reviews.

When the Living and the Deceased Cannot Agree on Organ Donation: A Survey of US Organ Procurement Organizations (OPOs)

L. Ross, E. Gordon, Y. Becker, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Rejection in Liver Allograft Recipients: Clinical Characterization and Management

J. Emond, J. Thistlethwaite, C. Broelsch, 1987 .

Bone Allografts Are Immunogenic and May Preclude Subsequent Organ Transplants

J. Thistlethwaite, M. Simon, Michael Y. Lee, 1997, Clinical orthopaedics and related research.

EXPERIENCEWITH RADICAL RESECTION INTHE MANAGEMENT OFPROXIMAL BILEDUCTCANCER

J. Emond, J. Thistlethwaite, C. Broelsch, 1989 .

OKT3 THERAPY FOR HEPATIC ALLOGRAFT REJECTION: DIFFERENTIAL RESPONSE IN ADULTS AND CHILDREN

J. Emond, E. Woodle, J. Thistlethwaite, 1991, Transplantation.

Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.

L. Schumm, J. Thistlethwaite, S. Sprague, 2004, Transplantation.

Racial disparities in reaching the renal transplant waitlist: is geography as important as race?

L. Ross, J. Thistlethwaite, M. Saunders, 2015, Clinical transplantation.

Prolongation of human pancreatic islet xenografts by pretreatment of islets with anti-human ICAM-1 monoclonal antibody.

A. Montag, J. Bluestone, J. Thistlethwaite, 1994, Transplantation proceedings.

OKT3 TREATMENT OF STEROID‐RESISTANT RENAL ALLOGRAFT REJECTION

A. Gaber, J. Thistlethwaite, C. Broelsch, 1987, Transplantation.

OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival.

A. Monaco, Shu-chen Wu, P. Vereerstraeten, 1996, Kidney international.

Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression.

J. Bluestone, A. Collins, E. Woodle, 1992, Journal of Immunology.

Biliary complications in living donor liver transplantation.

E. Woodle, J. Thistlethwaite, D. Bruce, 1997, Transplantation proceedings.

Attitudes of Lay Stakeholders and Transplant Professionals About Disclosure to Living Kidney Donors in Exchanges and Chains

L. Ross, J. Thistlethwaite, A. Grubbs, 2016, Progress in transplantation.

To tell or not to tell: attitudes of transplant surgeons and transplant nephrologists regarding the disclosure of recipient information to living kidney donors

L. Ross, J. Thistlethwaite, D. Mandelbrot, 2015, Clinical transplantation.

Age Should Not Be Considered in the Allocation of Deceased Donor Kidneys

L. Ross, J. Thistlethwaite, 2012, Seminars in dialysis.

Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts.

G. Szot, J. Thistlethwaite, J. Hart, 1999, Transplantation Proceedings.

The use of the T-cell flow cytometry crossmatch to evaluate the significance of positive B-cell serologic crossmatches in cadaveric donor renal transplantation.

J. Thistlethwaite, F. Stuart, T. Heffron, 1990, Transplantation proceedings.

Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience.

J. Bluestone, E. Woodle, R. Zivin, 1998, Transplantation proceedings.

Potential inefficiency of a proposed efficiency model for kidney allocation.

L. Ross, J. Thistlethwaite, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Oscillatory Insulin Secretion After Pancreas Transplant

M. Byrne, J. Sturis, K. Polonsky, 1993, Diabetes.

An Empirical Investigation of Physicians’ Attitudes Toward Intrasibling Kidney Donation by Minor Twins

L. Ross, J. Thistlethwaite, M. Josephson, 2008, Transplantation.

OKT3 induction in pediatric renal transplantation

J. Thistlethwaite, S. Bartosh, A. Aronson, 1993, Pediatric Nephrology.

Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides.

A. Montag, J. Thistlethwaite, Y. Zeng, 1995, Transplantation proceedings.

Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function.

E. Woodle, J. Thistlethwaite, D. Bruce, 1995, Transplantation Proceedings.

Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal allograft rejection.

D. Jeyarajah, E. Woodle, J. Thistlethwaite, 1995, Transplantation proceedings.

Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts.

J. Thistlethwaite, J. Hart, K. Newell, 1998, Transplantation Proceedings.

Allograft rejection in pediatric recipients of living related liver transplants

J. Thistlethwaite, E. Alonso, J. Piper, 1996, Hepatology.

E. Woodle, J. Thistlethwaite, K. Newell, 1994, Transplant international : official journal of the European Society for Organ Transplantation.

Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy.

H. Conjeevaram, E. Woodle, J. Thistlethwaite, 1997, Transplantation proceedings.

Successful use of tacrolimus for initial rejection episodes after liver transplantation.

H. Conjeevaram, T. Schiano, E. Woodle, 1998, Transplantation proceedings.

Equal Opportunity Supplemented by Fair Innings: Equity and Efficiency in Allocating Deceased Donor Kidneys

L. Ross, S. Gentry, J. Thistlethwaite, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

EARLY CORTICOSTEROID CESSATION AT ONE WEEK FOLLOWING KIDNEY TRANSPLANT UNDER TACROLIMUS AND MYCOPHENOLATE MOFETIL (MMF) IMMUNOSUPPRESION, THREE‐YEAR FOLLOW‐UP.: Abstract# 88

S. Kulkarni, J. Thistlethwaite, D. Bruce, 2000 .

Reversal of accelerated renal allograft rejection with FK 506.

E. Woodle, J. Thistlethwaite, M. Haas, 1997, Clinical transplantation.

Retransplantation for failed hepatic allografts in children.

E. Woodle, J. Thistlethwaite, D. Bruce, 1997, Transplantation proceedings.

Pediatric liver transplantation at the University of Chicago Hospitals.

E. Woodle, J. Thistlethwaite, K. Newell, 1992, Clinical transplants.

Immunohistochemical detection of antibody in tissue sections of non-perfused and ex vivo-perfused organs using a tetrazolium alkaline phosphatase substrate

W. Franklin, J. Thistlethwaite, M. Doria, 2004, Histochemistry.